In Interviews, PWS Caregivers Find DCCR Helps to Ease Troubling Behaviors

In Interviews, PWS Caregivers Find DCCR Helps to Ease Troubling Behaviors

293733

In Interviews, PWS Caregivers Find DCCR Helps to Ease Troubling Behaviors

In interviews, most caregivers of people with Prader-Willi syndrome (PWS) reported an easing in patients’ behavioral symptoms after 13 or more weeks of treatment with diazoxide choline controlled release (DCCR) tablets in a Phase 3 trial or its ongoing extension study. Interviews were given to 48 caregivers of enrolled patients after the 13-week main trial concluded and failed to meet its main goal. Subsequent analyses suggested that the COVID-19 pandemic, which erupted during the trial, affected its…

You must be logged in to read/download the full post.